Profound Medical (NASDAQ:PROF) Price Target Lowered to $22.0

Profound Medical (NASDAQ:PROF – Get Rating) had its target price reduced by Raymond James from $23.00 to $22.00 in a report published on Monday morning, BayStreet.CA reports. Raymond James currently has an outperform rating on the stock. PROF has been the topic of a number of other reports. Zacks Investment Research cut Profound Medical from […]

Related Keywords

Raymond James , Letko Brosseau Associates Inc , Raymond James Financial Services Advisors Inc , Geode Capital Management , Zacks Investment Research , Raymond James Associates , Nasdaq , Investment Management , Profound Medical , Get Rating , Investment Research , Capital Management , James Financial Services Advisors , Letko Brosseau , Nasdaq Prof , Prof , Medical , Lower Price Target ,